Oligonucleotide therapies are among the most promising biological therapeutics. They target disease at a different stage of ...

For decades, lab-made antibodies have been used to support patients fighting specific diseases. These treatments have become ...

Learn how analytical methodologies can be used to identify RSV pre- and post-fusion proteins for vaccine development.

Here, we discuss strategies to select the best therapeutic antigen targets, to optimize the structure of IgG antibodies and to design related or new structures with additional functions.

The influenza A virus genome consists of eight segments of single-stranded, negative-sense viral RNA, which encode multiple ...

In diseases like Parkinson's and Alzheimer's, specific proteins misfold and clump together, forming toxic aggregates that damage brain ...

Fresh off winning a Nobel Prize last year, and previously tackling antibodies and peptides, the University of Washington’s ...

Detecting toxic forms of tau before they weave into dense thickets of tangles could pave the way for earlier diagnosis and ...

UNIGE scientists have developed a groundbreaking technology that creates synthetic molecules mimicking antibodies, potentially revolutionizing disease treatments.

ACD/Labs recently released their 2025 Structure Elucidation & Verification Report, discussing how informatics trends have ...

The importance of a strategic approach and proper due diligence in unlocking the full potential of these arrangements.

A new startup from one of the key scientists at Google DeepMind exits stealth today with $50 million in funding.